Paddy Wall, BSc, MBA, senior manager, strategic partnerships, Longboat Clinical, told us the basis of the partnership is to provide the peer-reviewed quality management system (QMS) framework to clinical site staff, “to ensure each site on a clinical study has a top class QMS infrastructure.”
As per the agreement, the Avoca Quality Consortium (AQC) will provide the peer-reviewed QMS framework documentation, while Longboat will deliver the infrastructure to sites through its validated site engagement platform.
Wall said, “This ensures that sites actively participating in research have access to this valuable QMS infrastructure.”
Made up of nearly 100 pharma, biotech, contract research organization (CRO), and other provider companies, AQC is a pre-competitive collaborative established by life sciences consulting firm The Avoca Group.
“Many investigator sites participating in clinical research lack the bandwidth or expertise required to create a QMS worthy of the dedicated research facilities,” Wall added.
“This partnership ensures that these institutions have access to a peer-reviewed framework at a time they need it most – when they are actively engaging in a clinical trial.”
